Alberto Albertini

This advanced training program is designed to provide cardiac surgeons with comprehensive education and practical experience in the Ozaki aortic valve reconstruction technique. The course combines theoretical presentations, clinical case discussions, live surgical demonstrations, and hands-on training, offering participants a unique opportunity to deepen their understanding and skills in this innovative procedure.

Course Highlights:

·       Introduction and Welcome Address: Overview of educational goals and course objectives (Giuseppe Speziale)

·       Ozaki Procedure Overview: Technical introduction and clinical insights (Alberto Albertini)

·       Clinical Case Presentations: Patient selection, imaging, and surgical strategy discussions (Giuseppe Visicchio)

·       Live Surgery & Interactive Training: Real-time procedures with intraoperative commentary, focus on operative setup, instrumentation, team coordination, and opportunities for Q&A

·       Hands-on Practice: Training on dedicated models to reproduce the technique in professional practice

·       Debriefing and Final Remarks: Consolidation of learning objectives and key takeaways

The program is designed to support knowledge transfer, foster interactive learning, and enhance practical skills, ensuring that participants can confidently apply the Ozaki technique in their own clinical practice. This course represents an exclusive educational opportunity within MICS Academy’s portfolio, leveraging the expertise of leading international faculty and high-volume surgical centers.

Aortic valve disease in young patients still represents an unresolved  clinical challenge. Current surgical options, such as replacement with  echanical or biological prostheses, present significant limitations in 
terms of durability, the need for anticoagulation, and long-term quality of life.

In this context, innovative techniques such as aortic neocuspidization according to Ozaki, which involves the reconstruction of the aortic  valve with autologous pericardium treated with glutaraldehyde, are 
emerging.

This method, introduced with the aim of offering a durable,  biocompatible solution without the need for anticoagulant therapy, is  gaining increasing interest, especially for younger or pediatric patients.

The 3rd MICS Academy course, titled "MIDCAB and Multivalvular Minimally Invasive Approach", will be held in Bari, Italy, featuring live surgery sessions and expert-led training. The program includes:

• A welcome and theoretical session on Sept. 18 in Polignano a Mare
• Live surgical procedures and interactive training on Sept. 19 at Santa Maria Hospital
• Focus areas: patient selection, imaging, surgical strategy, instrumentation, and team coordination

The course is limited to 12 participants.